Filing Flows › NovoCure (NVCR) › How it makes money
How NovoCure (NVCR) makes money
NovoCure (NVCR) made $193M of revenue in the third quarter 2026 (Q3 2026), +16% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $193M | 100.0% |
| Income tax | $2.6M | 1.3% |
| Operating cash flow | $22.7M | 11.7% |
| Free cash flow | $15.7M | 8.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $193M | +16% |
| Q2 2026 | $184M | +16% |
| Q1 2026 | $174M | +12% |
| Q4 2025 | $174M | +8% |
| Q3 2025 | $167M | +8% |
| Q2 2025 | $159M | +6% |
| Q1 2025 | $155M | +12% |
From NovoCure's 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does NovoCure make money?
NovoCure (NVCR) made $193M of revenue in the third quarter 2026 (Q3 2026), +16% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.